CHM and choroideremia: That study would not have been possible without earlier lab research by Miguel Seabra, PhD, who received more than $1.5 million from the Foundation for his efforts to characterize the CHM gene, develop a rodent model of choroideremia, and evaluate early versions of the CHM gene therapy in lab studies.